Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Halbmayer

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Wiener Medizinische Wochenschrift (1946)|January 1, 1993
[Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction]W M Halbmayer, C Mannhalter, C Feichtinger, et al.
Journal of the American Academy of Dermatology|May 1, 1993
Ischemic venous thrombosis caused by a distinct disturbance of the extrinsic clotting systemP Duschet, W Seifert, W M Halbmayer, et al.
Thrombosis and Haemostasis|May 4, 1992
Histidine-rich glycoprotein (HRG) in uncomplicated pregnancy and mild and moderate preeclampsiaW M Halbmayer, P Hopmeier, C Feichtinger, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 14, 1997
APC resistance and factor V Leiden (FV:Q506) mutation in patients with ischemic cerebral events. Vienna Thrombophilia in Stroke Study Group (VITISS)W M Halbmayer, A Haushofer, V Angerer, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 13, 2001
HCV genotypes and age distribution in patients of Vienna and surrounding areasA C Haushofer, C Kopty, R Hauer, et al.
Thrombosis Research|September 28, 1999
Prothrombin complex concentrates: indications, contraindications, and risks: a task force summaryP Hellstern, W M Halbmayer, M Köhler, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1993
[Detection of lupus anticoagulants in the routine blood coagulation laboratory exemplified by 36 patients with systemic lupus erythematosus]W M Halbmayer, A Haushofer, W Schratzberger, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1994
Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimenA Haushofer, W M Halbmayer, M Dittel, et al.
Coronary Artery Disease|May 1, 1994
Prevalence of factor XII (Hageman factor) deficiency among 426 patients with coronary heart disease awaiting cardiac surgeryW M Halbmayer, A Haushofer, J Radek, et al.
Coronary Artery Disease|May 1, 1995
Platelet size, fibrinogen and lipoprotein(a) in coronary heart diseaseW M Halbmayer, A Haushofer, J Radek, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Wiener Medizinische Wochenschrift (1946)|January 1, 1993
[Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction]W M Halbmayer, C Mannhalter, C Feichtinger, et al.
Journal of the American Academy of Dermatology|May 1, 1993
Ischemic venous thrombosis caused by a distinct disturbance of the extrinsic clotting systemP Duschet, W Seifert, W M Halbmayer, et al.
Thrombosis and Haemostasis|May 4, 1992
Histidine-rich glycoprotein (HRG) in uncomplicated pregnancy and mild and moderate preeclampsiaW M Halbmayer, P Hopmeier, C Feichtinger, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 14, 1997
APC resistance and factor V Leiden (FV:Q506) mutation in patients with ischemic cerebral events. Vienna Thrombophilia in Stroke Study Group (VITISS)W M Halbmayer, A Haushofer, V Angerer, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 13, 2001
HCV genotypes and age distribution in patients of Vienna and surrounding areasA C Haushofer, C Kopty, R Hauer, et al.
Thrombosis Research|September 28, 1999
Prothrombin complex concentrates: indications, contraindications, and risks: a task force summaryP Hellstern, W M Halbmayer, M Köhler, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1993
[Detection of lupus anticoagulants in the routine blood coagulation laboratory exemplified by 36 patients with systemic lupus erythematosus]W M Halbmayer, A Haushofer, W Schratzberger, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1994
Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimenA Haushofer, W M Halbmayer, M Dittel, et al.
Coronary Artery Disease|May 1, 1994
Prevalence of factor XII (Hageman factor) deficiency among 426 patients with coronary heart disease awaiting cardiac surgeryW M Halbmayer, A Haushofer, J Radek, et al.
Coronary Artery Disease|May 1, 1995
Platelet size, fibrinogen and lipoprotein(a) in coronary heart diseaseW M Halbmayer, A Haushofer, J Radek, et al.
Pageof 4